Skip to product information
1 of 1

Phospho-Myosin Light Chain 2 (Ser19) Recombinant Rabbit mAb (S-3335-18)

Phospho-Myosin Light Chain 2 (Ser19) Recombinant Rabbit mAb (S-3335-18)

Catalog Number: S0B6797 Application: WB Reactivity: Mouse Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rabbit
Antigen Phospho-Myosin Light Chain 2 (Ser19)
Synonyms Myosin regulatory light polypeptide 9, Myosin regulatory light chain 2, smooth muscle isoform, Myosin regulatory light chain 9, Myl9, Myrl2
Immunogen Synthetic Peptide
Location Cytoplasm, Cytoskeleton
Accession Q9CQ19
Clone Number S-3335-18
Antibody Type Recombinant mAb
Isotype IgG
Application WB
Reactivity Ms
Positive Sample C2C12, C2C12 (treated with 50 µM ML-7 for 15 minutes)
Purification Protein A
Concentration 0.5 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
Dot Blot 1:1000
WB 1:1000-1:2000 Ms

Background

Phospho-Myosin Light Chain 2 (Ser19) refers to the specific post-translational modification of the regulatory myosin light chain (MLC2, also known as MLC20 in smooth muscle or MLC2a/2b in striated muscle) where a phosphate group is added to the serine residue at position 19. This phosphorylation event is primarily catalyzed by Myosin Light Chain Kinase (MLCK) in response to increased intracellular calcium levels, although Rho-associated kinase (ROCK) can also contribute, particularly in smooth muscle tone regulation. The addition of the phosphate group at Ser19 induces a conformational change in the myosin head, enabling it to interact with actin filaments and initiate ATP-dependent cross-bridge cycling, which is the fundamental mechanism driving muscle contraction and non-muscle cell motility, such as cytokinesis and cell migration. Consequently, detection of Phospho-MLC2 (Ser19) is widely used as a key biomarker for assessing cellular contractility and cytoskeletal dynamics in various physiological and pathological contexts.

Picture

Western Blot

WB result of Phospho-Myosin Light Chain 2 (Ser19) Recombinant Rabbit mAb
Blocking/Diluting buffer and concentration: 5% NFDM/TBST
Primary antibody: Phospho-Myosin Light Chain 2 (Ser19) Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated C2C12 whole cell lysate 20 µg
Lane 2: C2C12 treated with 50 µM ML-7 for 15 minutes whole cell lysate 20 µg
Lane 3: C2C12 whole cell lysate 20 µg
Secondary antibody: Goat Anti- rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 20 kDa
Observed MW: 22 kDa

Dot Blot

Dot blot result of Phospho-Myosin Light Chain 2 (Ser19) Recombinant Rabbit mAb
Lane 1: Myosin Light Chain 2 (Ser19) phospho peptide
Lane 2: Myosin Light Chain 2 phospho peptide
Lane 3: Myosin Light Chain 2 (Ser19) unmodified peptide
Primary antibody: Phospho-Myosin Light Chain 2 (Ser19) Recombinant Rabbit mAb at 1/1000 dilution
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution